View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NSF to Attend IPEC Europe Annual Excipients Forum, Malta

NSF has announced it will be attending the IPEC Europe Excipients Forum in Malta.

Join NSF at this dynamic conference in Malta on the 31 January, which is recognised to be one of the key events for pharmaceutical excipients in Europe.

At 8:45am, NSF International’s executive director of pharmaceutical biotech Dr Pete Gough will deliver a session on the potential impacts of Brexit on pharmaceutical supply chains.

The theme of this year’s forum is excipient integrity. The programme will cover many topics, including best practices and insights that can help your company adapt to current and future challenges.

This event provides an opportunity to network and learn more about the latest developments on pharmaceutical excipients. Pete will be on hand to answer all your questions and you can also get more information on NSF’s pharma biotech services, including its 2019 European training offering.

Accommodation will be on-site at The Westin Dragonara Resort. Make an enquiry to find out more.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology